Lipocine (LPCN) Held by Superinvestors
LIPOCINE INC (LPCN) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $177,175 based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Renaissance Technologies LLC is currently the largest disclosed institutional shareholder of LPCN tracked by InsiderSet, reporting ownership valued at approximately $177,175 in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $99,660.96, representing an estimated loss of -43.75% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed LPCN value among the investors covered in this analysis. Major shareholders include Renaissance Technologies LLC, and several other long-term asset managers with concentrated positions in LIPOCINE INC (LPCN).
This page ranks the largest institutional LPCN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Jim Simons | 0.00% | 69,209 | $177,175 | $99,661 | -$77,514 | -43.75% |
Frequently asked questions about LPCN
Who are the largest superinvestors holding LPCN?
The largest superinvestors holding LPCN in the latest SEC Form 13F filings include Renaissance Technologies LLC. InsiderSet ranks these superinvestors by their latest reported LPCN position.
What does the LPCN superinvestors page include?
This page tracks LPCN positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. LIPOCINE INC (LPCN) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold LPCN?
InsiderSet currently tracks 1 superinvestors reporting LPCN holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own LPCN.
How much LPCN stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $177,175 in LPCN holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were LPCN superinvestor holdings last updated?
The latest LPCN superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor LPCN holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its LPCN position after the reporting date.
Are superinvestors buying or selling LPCN?
Buying and selling can be analyzed by comparing LPCN positions across consecutive 13F reporting periods. InsiderSet's LPCN Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View LPCN ownership changes.
How have superinvestor LPCN holdings changed over time?
InsiderSet tracks LPCN holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.